ACTB and Cirrhosis: The dramatic decline in CYP4A11 mRNA and protein (Figures 4B, C) in cirrhosis has been confirmed with multiple CYP4A11 primer sets and two different P4504A11 peptide-specific antibodies compared to β-actin used as a loading control (Figure 4D).